Drug shortages
Supply-availability records maintained by the FDA Drug Shortages program. A record tracks whether a specific presentation is available, limited, or unavailable, and the reason the manufacturer gave. Shortages are common and often resolve; always confirm current supply with a dispensing pharmacy.
1,601 records · 1,153 current · source: FDA Drug Shortages
| Status | Availability | Generic name | Presentation | Company | Updated |
|---|---|---|---|---|---|
| Current | Limited Availability | Bupivacaine Hydrochloride Injection | Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25%… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Midazolam Hydrochloride Injection | Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Rocuronium Bromide Injection | Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Sodium Acetate Injection | Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Limited Availability | Liraglutide Injection | Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) | Novo Nordisk, Inc. | September 22, 2026 |
| Current | Available | Rocuronium Bromide Injection | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) | XGen Pharmaceuticals DJB, Inc. | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Sterile Water Injection | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-99) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Sodium Acetate Injection | Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%,… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Meperidine Hydrochloride Injection | Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Sufentanil Citrate Injection | Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Furosemide Injection | Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unvailable | Promethazine Hydrochloride Injection | Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6) | XGen Pharmaceuticals DJB, Inc. | September 22, 2026 |
| Current | Available | Sterile Water Injection | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-50) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Ketorolac Tromethamine Injection | Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Limited Availability | Lorazepam Injection | Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dextrose Monohydrate 5% Injection | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-20) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Unavailable | Morphine Sulfate Injection | Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dobutamine Hydrochloride Injection | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Liraglutide Injection | Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20) | Novo Nordisk, Inc. | September 22, 2026 |
| Current | Available | Methotrexate Sodium Injection | Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-41) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Hydromorphone Hydrochloride Injection | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Bupivacaine Hydrochloride and Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dextrose Monohydrate 5% Injection | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-00) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Methotrexate Sodium Injection | Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-124-40) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Etomidate Injection | Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Midazolam Hydrochloride Injection | Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Sodium Acetate Injection | Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Limited Availability | Liraglutide Injection | Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12) | Novo Nordisk, Inc. | September 22, 2026 |
| Current | Limited Availability | Midazolam Hydrochloride Injection | Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dobutamine Hydrochloride Injection | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Sodium Acetate Injection | Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Bupivacaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dextrose Monohydrate 50% Injection | Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Morphine Sulfate Injection | Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Hydromorphone Hydrochloride Injection | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Promethazine Hydrochloride Injection | Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3) | XGen Pharmaceuticals DJB, Inc. | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Marcaine, Injection, 225 mg/30 mL (NDC 0409-2253-25) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dobutamine Hydrochloride Injection | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Morphine Sulfate Injection | Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Bupivacaine Hydrochloride And Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dextrose Monohydrate 10% Injection | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Methotrexate Sodium Injection | Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-10) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Sterile Water Injection | Bacteriostatic Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Limited Availability | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Midazolam Hydrochloride Injection | Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Amino Acid Injection | Plenamine, Injection, 0.15 (NDC 0264-4500-00) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dobutamine Hydrochloride Injection | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (1… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Marcaine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1530-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Limited Availability | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Rocuronium Bromide Injection | Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Sterile Water Irrigant | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-00) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Ketorolac Tromethamine Injection | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Liraglutide Injection | Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22) | Novo Nordisk, Inc. | September 22, 2026 |
| Current | Available | Sterile Water Injection | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-20) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Atropine Sulfate Injection | Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL)… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Methotrexate Sodium Injection | Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-25) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Heparin Sodium Injection | Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-1005-20) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Amino Acid Injection | TrophAmine 10%, Injection, 0.1 (NDC 0264-1933-10) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Rocuronium Bromide Injection | Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dopamine Hydrochloride Injection | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dopamine Hydrochloride Injection | Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Sterile Water Injection | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-10) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Furosemide Injection | Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Furosemide Injection | Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Morphine Sulfate Injection | Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Midazolam Hydrochloride Injection | Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/2 mL (1%; 10 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-2253-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Fentanyl Citrate Injection | Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Dopamine Hydrochloride Injection | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC… | B. Braun Medical Inc. | September 22, 2026 |
| Current | Unavailable | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Bupivacaine Hydrochloride And Epinephrine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Marcaine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-2510-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Hydromorphone Hydrochloride Injection | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC… | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Rocuronium Bromide Injection | Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Meperidine Hydrochloride Injection | Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dextrose Monohydrate 10% Injection | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC… | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Morphine Sulfate Injection | Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Marcaine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-7535-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Midazolam Hydrochloride Injection | Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Marcaine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-5010-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dextrose Monohydrate 70% Injection | Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Meperidine Hydrochloride Injection | Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Sterile Water Irrigant | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-10) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dextrose Monohydrate 10% Injection | Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-00) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Dextrose Monohydrate 5% Injection | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-10) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Heparin Sodium Injection | Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1165-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Sodium Bicarbonate Injection | Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dopamine Hydrochloride Injection | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Limited Availability | Liraglutide Injection | Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13) | Novo Nordisk, Inc. | September 22, 2026 |
| Current | Available | Hydromorphone Hydrochloride Injection | Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Bupivacaine Hydrochloride Injection | Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Rocuronium Bromide Injection | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) | XGen Pharmaceuticals DJB, Inc. | September 22, 2026 |
| Current | Available | Sodium Acetate Injection | Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Hydromorphone Hydrochloride Injection | Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Bupivacaine Hydrochloride and Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Marcaine, Injection, 250 mg/50 mL (NDC 0409-0525-25) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dopamine Hydrochloride Injection | Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Hydromorphone Hydrochloride Injection | Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Limited Availability | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Amino Acid Injection | Plenamine, Injection, 0.15 (NDC 0264-4500-05) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Fentanyl Citrate Injection | Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Hydromorphone Hydrochloride Injection | Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Methotrexate Sodium Injection | Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-38) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Bupivacaine Hydrochloride And Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dextrose Monohydrate 5% Injection | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-31) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Unavailable | Epinephrine Bitartrate, Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (0.5%; 1:200,000) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Bupivacaine Hydrochloride Injection | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dobutamine Hydrochloride Injection | Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (2… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL)… | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Dobutamine Hydrochloride Injection | Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Unavailable | Midazolam Hydrochloride Injection | Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01) | Hospira, Inc., a Pfizer Company | September 22, 2026 |
| Current | Available | Dextrose Monohydrate 5% Injection | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-32) | B. Braun Medical Inc. | September 22, 2026 |
| Current | Available | Dexmedetomidine Hydrochloride Injection | Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01) | Pfizer Inc. | September 21, 2026 |
| Current | Limited Availability | Penicillin G Benzathine Injection | Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Dexmedetomidine Hydrochloride Injection | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Dexmedetomidine Hydrochloride Injection | Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Dexmedetomidine Hydrochloride Injection | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Dexmedetomidine Hydrochloride Injection | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10) | Pfizer Inc. | September 21, 2026 |
| Current | Unavailable | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02) | Pfizer Inc. | September 21, 2026 |
| Current | Limited Availability | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03) | Pfizer Inc. | September 21, 2026 |
| Current | Limited Availability | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Dexmedetomidine Hydrochloride Injection | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50) | Pfizer Inc. | September 21, 2026 |
| Current | Unavailable | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Dexmedetomidine Hydrochloride Injection | Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Clindamycin Phosphate Injection | Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Dexmedetomidine Hydrochloride Injection | Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20) | Pfizer Inc. | September 21, 2026 |
| Current | Limited Availability | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Clindamycin Phosphate Injection | Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18) | Pfizer Inc. | September 21, 2026 |
| Current | Limited Availability | Penicillin G Benzathine Injection | Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10) | Pfizer Inc. | September 21, 2026 |
| Current | Unavailable | Clindamycin Phosphate Injection | Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Dexmedetomidine Hydrochloride Injection | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Dexmedetomidine Hydrochloride Injection | Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02) | Pfizer Inc. | September 21, 2026 |
| Current | Unavailable | Penicillin G Benzathine Injection | Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10) | Pfizer Inc. | September 21, 2026 |
| Current | Limited Availability | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03) | Pfizer Inc. | September 21, 2026 |
| Current | Limited Availability | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Dexmedetomidine Hydrochloride Injection | Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01) | Pfizer Inc. | September 21, 2026 |
| Current | Available | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52) | Pfizer Inc. | September 21, 2026 |
| To Be Discontinued | Arsenic Trioxide Injection | Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 63323-637-10) | Fresenius Kabi USA, LLC | September 21, 2026 | |
| Current | Available | Methylprednisolone Acetate Injection | Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01) | Pfizer Inc. | September 21, 2026 |
| Current | Limited Availability | Methylprednisolone Acetate Injection | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05) | Sagent Pharmaceuticals | September 18, 2026 |
| Current | Available | Morphine Sulfate Injection | Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1… | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Liraglutide Injection | Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Fentanyl Citrate Injection | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Unavailable | Propranolol Hydrochloride Injection | Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Limited Availability | Lisdexamfetamine Dimesylate Capsule | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88) | Sun Pharmaceutical Industries, Inc. | September 18, 2026 |
| Current | Available | Fentanyl Citrate Injection | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Limited Availability | Lisdexamfetamine Dimesylate Capsule | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88) | Sun Pharmaceutical Industries, Inc. | September 18, 2026 |
| Current | Unavailable | Morphine Sulfate Injection | Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1… | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Unavailable | Methylphenidate Hydrochloride Tablet, Extended Release | Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88) | Sun Pharmaceutical Industries, Inc. | September 18, 2026 |
| Current | Unavailable | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate,… | Granules Pharmaceuticals Inc. | September 18, 2026 |
| Current | Unavailable | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate,… | Granules Pharmaceuticals Inc. | September 18, 2026 |
| Current | Available | Lisdexamfetamine Dimesylate Tablet, Chewable | Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88) | Sun Pharmaceutical Industries, Inc. | September 18, 2026 |
| Current | Available | Ketorolac Tromethamine Injection | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Sagent Pharmaceuticals | September 18, 2026 |
| Current | Unavailable | Promethazine Hydrochloride Injection | Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Bumetanide Injection | Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-10) | Sagent Pharmaceuticals | September 18, 2026 |
| Current | Available | Etomidate Injection | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate,… | Sandoz Inc. | September 18, 2026 |
| Current | Limited Availability | Lisdexamfetamine Dimesylate Capsule | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88) | Sun Pharmaceutical Industries, Inc. | September 18, 2026 |
| Current | Available | Midazolam Hydrochloride Injection | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Rocuronium Bromide Injection | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) | Sagent Pharmaceuticals | September 18, 2026 |
| Current | Available | Rocuronium Bromide Injection | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Limited Availability | Lisdexamfetamine Dimesylate Capsule | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88) | Sun Pharmaceutical Industries, Inc. | September 18, 2026 |
| Current | Unavailable | Methylphenidate Hydrochloride Tablet, Extended Release | Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88) | Sun Pharmaceutical Industries, Inc. | September 18, 2026 |
| Current | Unavailable | Dopamine Hydrochloride Injection | Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Unavailable | Remifentanil Hydrochloride Injection | Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| To Be Discontinued | Rivastigmine Film, Extended Release | Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93) | Mylan Pharmaceuticals Inc., a Viatris Company | September 18, 2026 | |
| Current | Available | Dexamethasone Sodium Phosphate Injection | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Unavailable | Rifampin Injection | Rifadin, Injection, 600 mg (NDC 0068-0597-01) | Sanofi-Aventis U.S. LLC | September 18, 2026 |
| Current | Unavailable | Dopamine Hydrochloride Injection | Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Unavailable | Methylphenidate Hydrochloride Tablet, Extended Release | Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88) | Sun Pharmaceutical Industries, Inc. | September 18, 2026 |
| Current | Available | Morphine Sulfate Injection | Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Unavailable | Fentanyl Citrate Injection | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Unavailable | Fentanyl Citrate Injection | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Etomidate Injection | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Limited Availability | Furosemide Oral Solution | Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-50) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Unavailable | Promethazine Hydrochloride Injection | Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Morphine Sulfate Injection | Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate,… | Sandoz Inc. | September 18, 2026 |
| Current | Unavailable | Clindamycin Phosphate Injection | Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04) | Sagent Pharmaceuticals | September 18, 2026 |
| Current | Available | Furosemide Oral Solution | Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-46) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Rocuronium Bromide Injection | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) | Sandoz Inc. | September 18, 2026 |
| Current | Available | Clindamycin Phosphate Injection | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC… | Sandoz Inc. | September 18, 2026 |
| Current | Available | Lidocaine Hydrochloride Injection | Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Unavailable | Fentanyl Citrate Injection | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Clindamycin Phosphate Injection | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC… | Sandoz Inc. | September 18, 2026 |
| Current | Available | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate,… | Sandoz Inc. | September 18, 2026 |
| Current | Unavailable | Lorazepam Injection | Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Ketorolac Tromethamine Injection | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Sagent Pharmaceuticals | September 18, 2026 |
| Current | Unavailable | Ifosfamide Injection | Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Unavailable | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate,… | Granules Pharmaceuticals Inc. | September 18, 2026 |
| Current | Unavailable | Ketorolac Tromethamine Injection | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Fentanyl Citrate Injection | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Meperidine Hydrochloride Injection | Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Lisdexamfetamine Dimesylate Tablet, Chewable | Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88) | Sun Pharmaceutical Industries, Inc. | September 18, 2026 |
| Current | Available | Sterile Water Injection | Sterile Water, Injection, 1 mL/1 mL (NDC 0641-6147-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Unavailable | Sufentanil Citrate Injection | Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Limited Availability | Lisdexamfetamine Dimesylate Capsule | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Valproate Sodium Injection | Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Clindamycin Phosphate Injection | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC… | Sandoz Inc. | September 18, 2026 |
| Current | Unavailable | Promethazine Hydrochloride Injection | Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Rocuronium Bromide Injection | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Limited Availability | Lisdexamfetamine Dimesylate Capsule | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-047-88) | Sun Pharmaceutical Industries, Inc. | September 18, 2026 |
| Current | Limited Availability | Lisdexamfetamine Dimesylate Capsule | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88) | Sun Pharmaceutical Industries, Inc. | September 18, 2026 |
| Current | Unavailable | Sufentanil Citrate Injection | Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Midazolam Hydrochloride Injection | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Unavailable | Remifentanil Hydrochloride Injection | Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |
| Current | Available | Remifentanil Hydrochloride Injection | Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10) | Hikma Pharmaceuticals USA, Inc. | September 18, 2026 |